Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2024, Vol. 29 ›› Issue (5): 535-542.doi: 10.12092/j.issn.1009-2501.2024.05.008

Previous Articles     Next Articles

Drug treatment options and research progress of adolescent endometriosis

HUANG Chunzhi, LIU Qinglan, SU Ran, SUN Nan   

  1. Department of Pharmacy, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China
  • Received:2023-11-13 Revised:2023-12-01 Online:2024-05-26 Published:2024-04-16

Abstract:

Endometriosis is a chronic, relapsing disease that requires long-term management. Adolescent endometriosis is a group that can be ignored, and the drug treatment is an important method for long-term management and fertility preservation. There are many kinds of drugs to treat endometriosis, such as NSAIDs, combined oral contraceptives (COC), progesterone, GnRHa. For the drug treatment selection, the characteristics of adolescents should be carefully considered and individualized treatment should be provided. In order to better long-term management, it is necessary to develop new treatments, which can effectively relieve endometriosis without damaging fertility. This review focuses on the drug treatment options and research progress of basic drug treatment for adolescent endometriosis, so as to delay disease progression, reduce adverse reactions, preserve fertility, and improve quality of life.

Key words: adolescent endometriosis, drug treatment, progress of drug therapy

CLC Number: